SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-263088
Filing Date
2010-11-17
Accepted
2010-11-17 16:59:44
Documents
10
Period of Report
2010-11-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 21508
2 CELL THERAPEUTICS, INC. PRESENTATION SLIDES dex991.htm EX-99.1 46412
3 GRAPHIC g121792ex99_1s1gbgd.jpg GRAPHIC 53009
4 GRAPHIC g121792ex99_1s2gbgd.jpg GRAPHIC 19133
5 GRAPHIC g121792ex99_1s3gbgd.jpg GRAPHIC 21136
6 GRAPHIC g121792ex99_1s4gbgd.jpg GRAPHIC 19783
7 GRAPHIC g121792ex99_1s5gbgd.jpg GRAPHIC 19806
8 GRAPHIC g121792ex99_1s6gbgd.jpg GRAPHIC 19807
9 GRAPHIC g121792ex99_1s7gbgd.jpg GRAPHIC 20463
10 GRAPHIC g121792ex99_1s8gbgd.jpg GRAPHIC 20870
  Complete submission text file 0001193125-10-263088.txt   338024
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 101200350
SIC: 2834 Pharmaceutical Preparations